サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1720536

前立腺肥大症手術の世界市場 - 市場規模、シェア、動向、産業分析：タイプ別、エンドユーザー別、地域別 - 市場予測（2025年～2034年）

Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
前立腺肥大症手術の世界市場 - 市場規模、シェア、動向、産業分析：タイプ別、エンドユーザー別、地域別 - 市場予測（2025年～2034年）
出版日: 2025年04月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前立腺肥大症手術の市場規模は、2034年までに211億9,000万米ドルに達する見込みです。

前立腺肥大症（BPH）手術市場は、しばしば頻尿、尿閉、膀胱炎などの症状を引き起こす前立腺肥大症の病状に対処することに焦点を当てています。BPHの手術は、薬物療法などの保存療法で症状を緩和できない場合に必要となります。市場は、特に前立腺肥大に罹患しやすい高齢男性の間でのBPHの罹患率の増加により、顕著な成長を示しています。レーザーを用いた治療、経尿道的前立腺切除術（TURP）、前立腺動脈塞栓術（PAE）などの低侵襲手術に対する需要の高まりが、前立腺肥大症手術市場の拡大に大きく寄与しています。

回復時間の短縮、合併症の減少、入院期間の短縮など、患者の転帰を向上させる手術技術の開発は、市場成長の主な促進要因の1つです。さらに、BPHに対する認識と診断の向上や、医療へのアクセスと償還政策の強化が、市場需要を促進しています。ロボット支援手術の導入やレーザー手術の採用の拡大が治療の情勢を変え、患者に多くの選択肢を提供し、前立腺肥大症手術市場全体の成長を促進しています。

市場力学には、外来患者による手術への選好の高まりも含まれ、これが手術技法の革新に拍車をかけています。さらに、複数の地域では可処分所得が増加しており、先進の治療へのアクセスが拡大しています。高齢化が進み、患者中心のソリューションへの注目が高まっていることから、市場の拡大の機会は大いにあります。市場では研究開発活動も活発化し、治療オプションをさらに最適化し、価値に基づく医療を推進する見通しです。その結果、市場は進化を続け、医療産業に携わるステークホルダーに有望な機会を提供すると予測されます。

前立腺肥大症手術市場レポートのハイライト

タイプ別では、その精密さ、最小の侵襲性、短い回復時間により、レーザー手術セグメントが2024年に大きな市場シェアを占めました。

エンドユーザー別では、利便性と費用対効果の高い治療オプションに対する患者の選好が高まっていることから、在宅医療セグメントが2024年に最大の市場シェアを占めました。

2024年、前立腺肥大症の高い有病率と先進の医療インフラにより、北米が最大の市場シェアを占めました。

アジア太平洋の前立腺肥大症治療市場は、医療へのアクセス向上と老年人口の増加により、予測期間にもっとも速く成長する見込みです。

世界の主要市場企業は、Allium、Alembic Pharmaceuticals Limited、Asahi Kasei Corporation、Asclepion Laser Technologies GmbH、Boston Scientific Corporation、Coloplast Group、Cook Medical、IPG Photonics Corporation、Karl Storz Se & Co.KG、Medifocus, Inc、Olympus Corporation、PNN Medical A/S、ProstaLund Ab、PROCEPT BioRobotics Corporation、Quanta System、Richard Wolf GmbH、SRS Medical、Teleflex Incorporated、Urologix, LLC.などです。

当レポートでは、世界の前立腺肥大症手術市場について調査し、現在の市場力学の詳細な考察や、将来の市場成長に関する分析を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の前立腺肥大症手術市場の考察

  • 市場スナップショット
  • 前立腺肥大症手術の市場力学
    • 促進要因と機会
      • 低侵襲手術の採用の増加
      • 老年人口の拡大
    • 抑制要因と課題
      • 手術の高額な費用
  • PESTEL分析
  • 前立腺肥大症手術市場の用途の動向
  • バリューチェーン分析

第5章 世界の前立腺肥大症手術市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 経尿道的前立腺切除術（TURP）
  • レーザー手術
  • ウロリフト手術
  • Rezum手術
  • ロボット支援ウォータージェットアブレーション
  • 前立腺ステント
  • 経尿道的マイクロ波温熱療法（TUMT）
  • 前立腺経尿道的ニードルアブレーション（TUNA）
  • 前立腺動脈塞栓術（PAE）
  • その他の手術

第6章 世界の前立腺肥大症手術市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来手術センター、診療所
  • 在宅医療

第7章 世界の前立腺肥大症手術市場：地域別

  • 主な調査結果
  • イントロダクション
    • 前立腺肥大症手術市場の分析：地域別（2020年～2034年）
  • 北米
    • 北米：タイプ別（2020年～2034年）
    • 北米：エンドユーザー別（2020年～2034年）
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別（2020年～2034年）
    • 欧州：エンドユーザー別（2020年～2034年）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他の欧州
  • アジア太平洋
    • アジア太平洋：タイプ別（2020年～2034年）
    • アジア太平洋：エンドユーザー別（2020年～2034年）
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別（2020年～2034年）
    • 中東・アフリカ：エンドユーザー別（2020年～2034年）
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別（2020年～2034年）
    • ラテンアメリカ：エンドユーザー別（2020年～2034年）
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ

第8章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/協業/合意/公開

第9章 企業プロファイル

  • Allium
  • Alembic Pharmaceuticals Limited
  • Asahi Kasei Corporation
  • Asclepion Laser Technologies GmbH
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • IPG Photonics Corporation
  • Karl Storz Se & Co. KG
  • Medifocus, Inc.
  • Olympus Corporation
  • PNN Medical A/S
  • ProstaLund Ab
  • PROCEPT BioRobotics Corporatio
  • Quanta System
  • Richard Wolf GmbH
  • SRS Medical
  • Teleflex Incorporated
  • Urologix, LLC
図表

List of Tables:

  • Table 1 Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 3 North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 4 North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 5 U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 6 U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 7 Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 8 Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 9 Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 10 Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 11 UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 12 UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 13 France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 14 France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 15 Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 16 Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 19 Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 20 Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 23 Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 29 China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 30 China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 31 India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 32 India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 35 Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 39 South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 40 South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 49 UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 50 UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 51 Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 53 South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 54 South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 57 Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 59 Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 60 Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 63 Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 64 Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End User
  • Figure 9. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2024 & 2034 (USD Billion)
目次
Product Code: PM5490

The global benign prostatic hyperplasia surgical treatment market size is expected to reach USD 21.19 billion by 2034, according to a new study by Polaris Market Research. The report "Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User (Hospitals, Ambulatory Surgery Centers and Clinics, and Homecare Settings), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The benign prostatic hyperplasia (BPH) surgical treatment market focuses on addressing the medical condition of an enlarged prostate, which often leads to symptoms such as frequent urination, urinary retention, and bladder infections. Surgical treatments for BPH are necessary when conservative therapies like medications fail to alleviate symptoms. The market has seen notable growth, driven by an increasing incidence of BPH, especially among the aging male population, who are more susceptible to prostate enlargement. The rising demand for minimally invasive procedures, such as laser-based therapies, transurethral resection of the prostate (TURP), and prostate artery embolization (PAE), is significantly contributing to the benign prostatic hyperplasia surgical treatment market expansion.

Advancements in surgical technology, which offer improved patient outcomes with shorter recovery times, reduced complications, and minimal hospital stays, is one of the key factors fueling market development. Moreover, rising awareness and diagnosis of BPH, coupled with increased healthcare access and reimbursement policies, have propelled market demand. The introduction of robotic-assisted surgeries and the growing adoption of laser surgeries are transforming the treatment landscape, providing patients with more options and driving the overall benign prostatic hyperplasia surgical treatment market growth.

The market dynamics also include a growing preference for outpatient procedures, which has spurred innovation in surgical techniques. Additionally, rising disposable income in several regions is enabling greater access to advanced treatments. The market holds considerable opportunity for expansion as the population continues to age, with an increasing focus on patient-centric solutions. The market is also poised to witness more research and development efforts, further optimizing treatment options and promoting value-based care. Consequently, the market is expected to continue evolving, presenting promising opportunities for stakeholders involved in the healthcare industry.

Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights

In terms of type, the laser surgeries segment accounted for a significant market share in 2024 due to their precision, minimal invasiveness, and shorter recovery time.

Based on end user, the homecare settings segment accounted for the largest market share in 2024 due to growing patient preference for convenience and cost-effective treatment options.

In 2024, North America accounted for the largest market share due to the high prevalence of BPH and advanced healthcare infrastructure.

The Asia Pacific benign prostatic hyperplasia surgical treatment market is expected to witness the fastest growth during the forecast period due to increasing healthcare access and a rising elderly population.

Some of the global key market players are Allium; Alembic Pharmaceuticals Limited; Asahi Kasei Corporation; Asclepion Laser Technologies GmbH; Boston Scientific Corporation; Coloplast Group; Cook Medical; IPG Photonics Corporation; Karl Storz Se & Co. KG; Medifocus, Inc.; Olympus Corporation; PNN Medical A/S; ProstaLund Ab; PROCEPT BioRobotics Corporation; Quanta System; Richard Wolf GmbH; SRS Medical; Teleflex Incorporated; and Urologix, LLC.

Polaris Market Research has segmented the benign prostatic hyperplasia surgical treatment market report on the basis of type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Transurethral Resection of the Prostate (TURP)
  • Laser Surgeries
  • Urolift Procedures
  • Rezum Procedures
  • Robot-Assisted Waterjet Ablation
  • Prostatic Stents
  • Transurethral Microwave Thermotherapy (TUMT)
  • Transurethral Needle Ablation of the Prostate (TUNA)
  • Prostatic Arterial Embolization (PAE)
  • Other Procedures

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals
  • Ambulatory Surgery Centers and Clinics
  • Homecare Settings

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Benign Prostatic Hyperplasia Surgical Treatment Market Insights

  • 4.1. Benign Prostatic Hyperplasia Surgical Treatment Market - Market Snapshot
  • 4.2. Benign Prostatic Hyperplasia Surgical Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Adoption of Minimally Invasive Procedures
      • 4.2.1.2. Expanding Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Surgery
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Benign Prostatic Hyperplasia Surgical Treatment Market Application Trends
  • 4.6. Value Chain Analysis

5. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Transurethral Resection of the Prostate (TURP)
    • 5.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Resection of the Prostate (TURP), by Region, 2020-2034 (USD Billion)
  • 5.4. Laser Surgeries
    • 5.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Laser Surgeries, by Region, 2020-2034 (USD Billion)
  • 5.5. Urolift Procedures
    • 5.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Urolift Procedures, by Region, 2020-2034 (USD Billion)
  • 5.6. Rezum Procedures
    • 5.6.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Rezum Procedures, by Region, 2020-2034 (USD Billion)
  • 5.7. Robot-Assisted Waterjet Ablation
    • 5.7.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, Robot-Assisted Waterjet Ablation, by Region, 2020-2034 (USD Billion)
  • 5.8. Prostatic Stents
    • 5.8.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Stents, by Region, 2020-2034 (USD Billion)
  • 5.9. Transurethral Microwave Thermotherapy (TUMT)
    • 5.9.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Microwave Thermotherapy (TUMT), by Region, 2020-2034 (USD Billion)
  • 5.10. Transurethral Needle Ablation of the Prostate (TUNA)
    • 5.10.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Needle Ablation of the Prostate (TUNA), by Region, 2020-2034 (USD Billion)
  • 5.11. Prostatic Arterial Embolization (PAE)
    • 5.11.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Arterial Embolization (PAE), by Region, 2020-2034 (USD Billion)
  • 5.12. Other Procedures
    • 5.12.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Other Procedures, by Region, 2020-2034 (USD Billion)

6. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 6.4. Ambulatory Surgery Centers and Clinics
    • 6.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Ambulatory Surgery Centers and Clinics, by Region, 2020-2034 (USD Billion)
  • 6.5. Homecare Settings
    • 6.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)

7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Benign Prostatic Hyperplasia Surgical Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - North America
    • 7.3.1. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.3.2. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.3.3. Benign Prostatic Hyperplasia Surgical Treatment Market - U.S.
      • 7.3.3.1. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.3.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Canada
      • 7.3.4.1. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Europe
    • 7.4.1. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.3. Benign Prostatic Hyperplasia Surgical Treatment Market - UK
      • 7.4.3.1. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.4. Benign Prostatic Hyperplasia Surgical Treatment Market - France
      • 7.4.4.1. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Germany
      • 7.4.5.1. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Italy
      • 7.4.6.1. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Spain
      • 7.4.7.1. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.8. Benign Prostatic Hyperplasia Surgical Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Russia
      • 7.4.9.1. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.3. Benign Prostatic Hyperplasia Surgical Treatment Market - China
      • 7.5.3.1. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.4. Benign Prostatic Hyperplasia Surgical Treatment Market - India
      • 7.5.4.1. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Japan
      • 7.5.6.1. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.8. Benign Prostatic Hyperplasia Surgical Treatment Market - South Korea
      • 7.5.8.1. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Australia
      • 7.5.9.1. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.4. Benign Prostatic Hyperplasia Surgical Treatment Market - UAE
      • 7.6.4.1. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Israel
      • 7.6.5.1. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.6. Benign Prostatic Hyperplasia Surgical Treatment Market - South Africa
      • 7.6.6.1. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Latin America
    • 7.7.1. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Mexico
      • 7.7.3.1. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Brazil
      • 7.7.4.1. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Argentina
      • 7.7.5.1. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Allium
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Alembic Pharmaceuticals Limited
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Asahi Kasei Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Asclepion Laser Technologies GmbH
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Boston Scientific Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Coloplast Group
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Cook Medical
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. IPG Photonics Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Karl Storz Se & Co. KG
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Medifocus, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Olympus Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. PNN Medical A/S
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. ProstaLund Ab
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. PROCEPT BioRobotics Corporatio
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Quanta System
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Richard Wolf GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. SRS Medical
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development
  • 9.18. Teleflex Incorporated
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Development
  • 9.19. Urologix, LLC
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Development